| 摘要 |
The use of 2-aminobenzothiazoles of formula (I), wherein R is a straight or branched C1-5 alkyl, trifluoromethyl, pentafluoroethyl or pentafluoroethoxy radical, and enantiomers and pharmaceutically acceptable salts thereof, for treating Parkinson's disease and parkinsonian syndromes, is disclosed. |
